METHYPREDNISOLONE ACETATE INJECTABLE SUSPENSION; Multidose Vials

TEVA

Revision date : 2013-01-10

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

500-038-2/25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

EC/CAS

231-791-2/7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

N/A

EC/CAS

202-859-9

Name of the chemical

Benzyl alcohol (38)

Concentration

100-51- 231-449-

General Information

Revision date

2013-01-10

Product name

METHYPREDNISOLONE ACETATE INJECTABLE SUSPENSION; Multidose Vials

Chemical name

Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-,(6α,11β)-

1.2.2. Uses advised against

Other than Relevant Use

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is a clear, colorless, aqueous solution. Health In the workplace, exposure by inhalation and eye contact may cause irritation. Prolonged skin contact may cause irritation. May be harmful if swallowed. Therapeutic use can cause adverse effects on the cardiovascular, musculoskeletal and neurological systems, blood and eyes. Therapeutic use can result in increased susceptibility to infections and may exacerbate systemic fungal infections. Rare instances of anaphylactoid reactions have occurred in persons receiving corticosteroid therapy. May interfere with fertility in men, based on animal data. Limited evidence of harm to the fetus, based on animal information. These effects may be possible as a result of workplace exposure. Refer to Section 11 (Toxicological Information) for additional information on adverse effects. Flammability Hazards: This product is not flammable or combustible. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including carbon, phosphorous, sodium and nitrogen oxides). Reactivity Hazards: This product is not reactive. Environmental Hazards: The active ingredient may cause long-term harm to aquatic organisms. Release to the aquatic and terrestrial environment may have an adverse effect. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.